ClinicalTrials.Veeva

Menu

Evaluating the Effect of Injectable Platelet-rich Fibrin on Accelerating Orthodontic Tooth Movement

H

Hama University

Status

Enrolling

Conditions

Injectable Platelet-rich Fibrin
Tooth Mobility

Treatments

Behavioral: Placebo injection
Device: injectable form of PRF

Study type

Interventional

Funder types

Other

Identifiers

NCT06302296
Hama University/

Details and patient eligibility

About

One of the main goals of orthodontic treatment is the reduction of treatment time through faster tooth movement. The previous studies evaluating platelet-rich fibrin (PRF) and orthodontic tooth movement (OTM) are limited, which makes the results difficult to generalize.

Full description

One of the main goals of orthodontic treatment is the reduction of treatment time through faster tooth movement. The previous studies evaluating platelet-rich fibrin (PRF) and orthodontic tooth movement (OTM) are limited, which makes the results difficult to generalize. To this end, we set up this Randomized experiment to evaluate the effect of the injectable form of PRF (i-PRF) on OTM, using nonadditive containing i-PRF, which has higher levels of regenerative cells and growth factors compared with other PRF types because of the use of low centrifugation spee. Accordingly, we aimed to evaluate the effect of i-PRF on the rate of maxillary incisors leveling during comprehensive orthodontic treatment.

Enrollment

14 estimated patients

Sex

All

Ages

18 to 26 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patient's age (18-26). Severe or very severe irregularity of the upper incisors greater than (7 mm) according to Little's index, so it is recommended to extract the upper first premolar.

    • Class I or Class II malocclusion, first model according to Angle, with skeletal class I or II and a normal or mild vertical growth pattern.
    • All permanent upper teeth, up to the first molar, are present, with the possibility of attaching brackets to all teeth in a correct position.
    • The patient has good oral health.

Exclusion criteria

  • • The presence of any systemic disease that affects orthodontic dental movement.

    • Severe malalignment of one of the teeth (palatal quadrant, ectopic canine, ectopic premolar).
    • The patient has undergone previous orthodontic treatment.
    • The patient is subject to any drug treatment that may affect orthodontic dental movement (cortisone, non-steroidal anti-inflammatory drugs).
    • The patient has poor oral health.
    • Commitment to periodic follow-up appointments.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

14 participants in 2 patient groups

injectable form of PRF
Experimental group
Description:
A group of patients in which participants will be undergo to orthodontic treatment will be received a 0.9 ml injection of PRF after 1st premolar extraction.
Treatment:
Device: injectable form of PRF
traditional orthodontic treatment
Experimental group
Description:
A group of patients in which participants will be undergo to traditional orthodontic treatment will be received a Placebo injection after 1st premolar extraction.
Treatment:
Behavioral: Placebo injection

Trial contacts and locations

1

Loading...

Central trial contact

FADI JNAID, Associate Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems